| 09/03/2010 |
| Daily Telegraph |
| By: Presswatch |
| Scientists discover a trendy new superfood... the everyday egg |
| Nutrition scientists say the egg should be considered a superfood because of its ability to boost health and tackle obesity. In a study to be published in Nutrition and Food Science, researchers said that, despite being low in calories, eggs were a rich source of protein and were packed with amino acids for growth, vitamin D, vitamin B12, selenium, choline and antioxidants. The study analysed 71 research papers and reference documents that examined the nutritional composition of eggs and their role in diet. Nutrition scientists have recommended eating at least one egg a day. |
|
--------------------
|
| 09/03/2010 |
| Financial Times |
| By: Presswatch |
| Regulator finds ethics breach by AstraZeneca |
|
AstraZeneca failed to reflect accurately the side-effects of its top-selling antipsychotic drug, Seroquel, in an advertisement to doctors, a UK regulatory panel has ruled. A preliminary ruling by the Prescription Medicines Code of Practice Authority, the self-regulatory arm of the Association of the British Pharmaceutical Industry, found that AstraZeneca breached three points of the British pharmaceutical industry's code of practice with a marketing claim that Seroquel had "a favourable weight profile across the full dose range" compared with rival drugs. |
|
--------------------
|
| 09/03/2010 |
| The Guardian |
| By: Presswatch |
| Astra's star fades as cancer drug fails late-stage trial |
|
AstraZeneca yesterday reported that trials of Recentin against Avastin for colorectal patients had seen the former drug fail to record significant results. AZ's shares declined by 42.5p following the news. Analysts at Jefferies International said: "If the ruling goes against AstraZeneca, it would reduce mid-term earnings per share by around 25%. We continue to rate the stock an underperform, with a £24.50 target price." |
|
--------------------
|
| 09/03/2010 |
| International Herald Tribune |
| By: Presswatch |
| Rivals circle German generic drug 'jewel' |
|
Ratiopharm, a German generic pharmaceuticals firm, is being targeted by Pfizer, Teva and Actavis for takeover, according to reports. Pfizer is said to have bid as much as $4.1bn for Ratiopharm. Executives from Pfizer and Teva have travelled to Germany to present their proposals to Ratiopharm, according to analysts, who said Actavis was scheduled to do so this week. |
|
--------------------
|
| 09/03/2010 |
| The Sun |
| By: Presswatch |
| Genetics pain clue |
|
People who suffer more pain than others could have a gene mutation, according to researchers. Protein released by the gene - SCN9A - activates nerves for longer. The discovery could lead to the production of better painkillers and help to explain different responses in patients, according to the US-based National Academy of Sciences. |
|
--------------------
|
| 09/03/2010 |
| By: Presswatch |
| NHS and Health Sector News |
| The Times reports that a shortage of space in NHS hospitals means that patients are routinely treated in TV rooms, mop cupboards and corridors, according to a poll of more than 900 nurses for Nursing Times. The Daily Telegraph reports that a baby is fighting for his life after a junior doctor gave him 10 times the normal dose of a TB vaccine. The boy was injected with 0.5mg of the BCG vaccine instead of the usual 0.05mg dose. The Evening Standard reports that Cathy Warwick, general secretary of the Royal College of Midwives, has warned that London's maternity units risk becoming birth "factories" which fail to meet the needs of women. She said that the NHS closures and cutbacks will result in "large and impersonal" birthing centres, with some hospitals delivering up to 10,000 babies a year. |
|
--------------------
|
| [ End of selection ] |
| Top of the page |